ZahraGhiassi-NejadMDPhD

Physician

Dr. Ghiassi-Nejad is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Icahn School of Medicine at Mount SinaiResidency, Radiation Oncology, 2015 - 2019
Icahn School of Medicine at Mount SinaiResidency, Radiation Oncology, 2014 - 2018
Icahn School of Medicine at Mount SinaiClass of 2013

PubMed

36 citations
GSK3β phosphorylation of the KLF6 tumor suppressor promotes its transactivation of p21
Undine E. Lang, Peri Kocabayoglu, George Cheng, Zahra Ghiassi-Nejad, Úrsula Muñoz
Oncogene. 2013-09-19
11 citations
Overall Survival Trends and Clinical Characteristics of Plasmacytoma in the United States: A National Cancer Database Analysis
Z. Ghiassi-Nejad, Meng Ru, Erin Moshier, Sanders Chang, Sundar Jagannath
Clinical Lymphoma, Myeloma & Leukemia. 2019-05-01
33 citations
Reduced hepatic stellate cell expression of Kruppel-like factor 6 tumor suppressor isoforms amplifies fibrosis during acute and chronic rodent liver injury.
Zahra Ghiassi-Nejad, Virginia Hernandez-Gea, Christopher D. Woodrell, Ursula E. Lang, Katja Dumic
Hepatology. 2013-02-01

Prognostic Factors and Patterns of Locoregional Failure After Surgical Resection in Patients with Cholangiocarcinoma Without Adjuvant Radiation Therapy: Optimal Field Design for Adjuvant Radiation TherapyJuly 2017

For Advanced Sarcoma, Adding Lymphodepletion to HER2-Targeted CAR T-cell Therapy ExcitesApril 9th, 2019